Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

MONTELUKAST SODIUM

Awarded
SPE2DP-26-T-4642Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This solicitation, issued by the Department of Defense Medical Supply Chain Pharm FSA, is for the procurement of Montelukast Sodium 10 mg tablets in 30-count bottles. The requirement is for a Type I (Code K) item with a non-extendable shelf life of 18 months, and the product must be stored at a controlled room temperature. Based on historical procurement data, the estimated contract value is approximately $32,153.61. Delivery is required to a carrier outfitting material support center in Suffolk, Virginia, within 5 days after receipt of order, under FOB Destination terms. The contract is subject to rigorous regulatory and safety standards, as the drug is regulated by the FDA. Because the item may involve hazardous materials, contractors must provide a current Material Safety Data Sheet (MSDS) with each shipment and via email to the designated DLA mailbox. Packaging and marking must strictly adhere to various federal and international standards, including 49 CFR, ICAO, IMDG, and MIL-STD-129, with specific requirements for hazardous material labeling and military aircraft shipments. Additionally, the contract incorporates significant cybersecurity and information safeguarding clauses, such as DFARS 252.204-7012, requiring the protection of covered defense information and reporting of cyber incidents. All invoicing and receiving must be processed electronically through the Wide Area WorkFlow (WAWF) system.

General Info

DoD procurement of Montelukast Sodium 10mg tablets for delivery to Suffolk, Virginia.

Contract Value

$10.6

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

VA, USA

Set-Aside

NONE

Award Issued Date

Documents

2
PDF, High priority: read this firstrfq
High
PDF, High priority: read this firstaward
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Solicitation

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
Contacts1 person available
OfficeUSA
Office AddressUSA

Full Description

Show more
DLA award SPE2DP26V0919 posted on DIBBS. Awardee: MR UNLIMITED, LLC (CAGE 3W8H0) Total Contract Price: $10.60 Award Date: 09-08-2026 Solicitation: SPE2DP-26-T-4642 Line items: - MONTELUKAST SODIUM (NSN/Part 6505015049756, PR 7017824296)

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
Solicitation # 36E79727R0039
The Department of Veterans Affairs Enterprise Procurement Office intends to issue Request for Proposal 36E79727R0039 for an unrestricted procurement of Latanoprost Ophthalmic Solution. This contract will establish an uninterrupted source of supply for the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. Distribution will be managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The award will be granted to a single responsible offeror for a base period of one year with four pre-priced one-year option periods. The solicitation is expected to be issued in commercial item format per FAR Part 12 on approximately October 21, 2026, with a tentative closing date of November 4, 2026, under NAICS code 325412. Strict labeling and packaging requirements apply to this procurement. Offerors must provide the exact drug name as it appears on the label and a unique NDC number. The contractor's label must be the sole label on the product, and affixing labels over existing ones is prohibited; however, the label must allow VA labels to adhere securely on top. Additionally, vendors must comply with the American Academy of Ophthalmology’s recommended uniform color-coding system for the caps and labels of all topical ocular medications. This acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. All communications and submissions are to be handled electronically via SAM.gov, with James Sullivan serving as the primary point of contact.
Nac Pharmaceuticals (36E797)

POSTED

about 10 hours ago

DEADLINE

in 18 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS